Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIMROSE - A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF)

NCT07503704 is registered in ClinicalTrials.gov with Royal College of Surgeons, Ireland as lead sponsor.

NCT NCT07503704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIMROSE - A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF)
Lead sponsor
Royal College of Surgeons, Ireland
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2024
Completion date
October 1, 2035
Enrollment
69 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer